Search

Your search keyword '"Björk, Elisabeth"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Björk, Elisabeth" Remove constraint Author: "Björk, Elisabeth"
47 results on '"Björk, Elisabeth"'

Search Results

2. Production of fines from refined kraft pulp by fractionation with micro-perforated screens

3. Use of fines-enriched chemical pulp to increase CTMP strength

5. Some key aspects on screening of chemical pulp to achieve a fine fraction – a literature review

6. Production and application of fine fractions made of chemical pulp for enhanced paperboard strength

7. Production of a fine fraction using micro-perforated screens

15. PCR Analysis as a Method of Microbiological Control in Endodontic Treatment Is there a Correlation to Healing? A pilot study

16. Fines-enriched pulp as a strength agent in a CTMP middle ply

17. Production of pulps with an extremely high fines content for use as strength agent

18. Usage of Fines-Enriched Pulp to Increase Strength in CTMP

19. Single-stage hydrocyclone fractionation of refined bleached softwood pulp

20. Flow imaging characterisation of morphological changes of chemical pulp due to refining

22. Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults

23. Models for plasma glucose, HbA1c, and hemoglobin interrelationships in patients with type 2 diabetes following tesaglitazar treatment

25. Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes

26. Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes.

27. Islet antibodies and remaining beta-cell function 8 years after diagnosis of diabetes in young adults : a prospective follow-up of the nationwide Diabetes Incidence Study in Sweden

29. The incidence of Type 1 diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983 to 1998

30. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds

31. Factors predicting clinical remission in adult patients with type 1 diabetes

39. Temporary Preservation of β-Cell Function byDiazoxide Treatment in Childhood Type 1 Diabetes.

40. Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes.

41. CRP and IL-6 concentrations are associated with poor glycemic control despite preserved β-cell function during the first year after diagnosis of type 1 diabetes.

44. Remaning β-cell function eight years after diagnosis of autoimmune diabetes in young adults. : Relation to islet antibodies and clinical features

45. Characterization of morphological changes of chemical pulp fibres and fines due to refining

46. Electrochemical Characteristics of Lignin in CTMP for Paper Battery Electrodes.

47. CRP and IL-6 concentrations are associated with poor glycemic control despite preserved beta-cell function during the first year after diagnosis of type 1 diabetes.

Catalog

Books, media, physical & digital resources